Researchers have developed a new tool that will help scientists study how genes are expressed in our cells.
Novo Holdings’ acquisition of Catalent gains EC approval
Novo Holdings plans to divest three of Catalent’s global sites to Novo Nordisk. Credit: © 2024 Novo Nordisk A/S. Novo Holdings, the investment arm of